Bellerophon Therapeutics ... (BLPH)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.00

-100.00%

After-hours Dec 31, 1969, 07:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	65.00K	102.00K	147.00K	348.00K	362.00K	373.00K	400.00K	-	-	-	-
Gross Profit	-65.00K	-102.00K	-147.00K	-348.00K	-362.00K	-373.00K	-400.00K	-	-	-	-
Operating Income	-22.38M	-20.16M	-26.28M	-17.47M	-27.88M	-24.60M	-23.76M	-46.57M	-59.75M	-62.00M	-46.23M
Interest Income	-	-	-	-	378.00K	184.00K	95.00K	109.00K	79.00K	-	-
Pretax Income	-22.25M	-19.56M	-26.85M	-15.07M	-2.63M	-54.82M	-24.25M	-46.46M	-59.67M	-62.00M	-46.23M
Net Income	-19.83M	-17.76M	-24.73M	-13.27M	2.81M	-54.82M	-23.81M	-46.46M	-59.67M	-62.00M	-46.23M
Selling & General & Admin	6.02M	7.15M	8.39M	6.44M	7.62M	6.75M	7.11M	14.87M	13.78M	9.01M	7.18M
Research & Development	16.36M	13.02M	17.89M	11.03M	20.26M	17.85M	16.65M	33.37M	45.98M	52.98M	38.73M
Other Expenses	-	-	-	-674.00K	27.88M	24.60M	23.76M	48.23M	-	-	-
Operating Expenses	22.38M	20.16M	26.28M	17.47M	27.88M	24.60M	23.76M	46.57M	59.75M	62.00M	46.23M
Interest Expense	135.00K	5.00K	250.00K	-	-	-	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	22.38M	20.16M	26.28M	17.47M	27.88M	24.60M	23.76M	46.57M	59.75M	62.00M	46.23M
Income Tax	-2.42M	-1.80M	-2.13M	-1.80M	-5.44M	29.85M	-438.00K	1.18M	-	-	-
Shares Outstanding (Basic)	9.55M	9.50M	7.80M	4.50M	4.34M	2.60M	1.00M	817.85K	11.91M	12.91M	12.91M
Shares Outstanding (Diluted)	9.55M	9.50M	7.80M	4.50M	4.34M	2.60M	1.00M	817.85K	11.91M	12.91M	12.91M
EPS (Basic)	-2.08	-1.87	-3.17	-2.95	0.65	-21.11	-23.72	-56.81	-5.01	-4.8	-3.58
EPS (Diluted)	-2.08	-1.87	-3.17	-2.95	0.65	-21.11	-23.72	-56.81	-5.01	-4.8	-3.58
EBITDA	-22.18M	-20.16M	-26.71M	-14.72M	-2.26M	-54.45M	-23.85M	-46.08M	-59.37M	-61.57M	-46.14M
Depreciation & Amortization	65.00K	102.00K	147.00K	348.00K	362.00K	373.00K	400.00K	377.00K	388.00K	429.00K	85.00K